Concisemrcp Reviews 

Reply from Concisemrcp

Dec 10, 2018

At the end of the day, although the exam is a stepping stone the most important facet is your clinical practice. It is ideal to use the opportunity to deal with concepts you have been struggling with lest they remain a mystery long into your career.

I hope the distillation of many years of my struggle to understand these makes the path for you an easier one.

Reply from Concisemrcp

Dec 10, 2018

I'm glad that you enjoyed the course. All the topics are selected as those that are the hardest to understand, not the easiest to teach.

Best of luck with your exam!

Reply from Concisemrcp

Oct 14, 2018

Following our email correspondence I'm glad that you are now aware of the complexity of providing a course, all the background steps that are involved and costs incurred. Not withstanding, the course still sits as one of the cheapest MRCP part 1 courses you can attend and if you read the feedback below, although cheaper than others, the teaching quality is still outstanding.

Reply from Concisemrcp

Dec 11, 2018

Many thanks for your complementary review.

Reply from Concisemrcp

Oct 14, 2018

You can cover a greater number of topics in 5 days than you can in 2. This course is constructed to cover the absolute maximum material I believe one person can absorb in the given time - and ensure that they remember it.

The construction intertwines concepts together to enhance understanding, highlighting recurring themes to allow candidates to answer a question with confidence and improve clinical practice... It is not trying to emulate Pastest.

I would advise anyone looking for a course like Pastest to actually attend the Pastest course instead of conciseMRCP.

With this pattern of teaching it hopefully does feel like you have not been overloaded with topics, but during these 2 days we covered..

• Small vessel vasculitides • Wegener's vs. MPA vs. PAN vs. Churg • Conditions affecting the lung and kidney • Glomerulonephritis • Presentation of renal disease • Nephrotic vs nephritic syndrome • Light microscopy findings in glomerulonephritis • Immunofluorescence and glomerulonephritis • MSGN • IgA nephropathy / Berger's • Post streptococcal glomerulonephritis / diffuse proliferative GN • Minimal change disease • Membranous glomerulonephritis • Goodpasture's syndrome • Crescentic glomerulonephritis • Inflammatory bowel disease • Comparisons of UC and Crohn's and impact on diagnostic process • Treatment of IBD • Bowel cancer • HNPCC • FAP • Irritable bowel syndrome • Cushing’s • Localising investigations • Physiology of the normal pituitary axis • Features of cortisol excess • Hyperaldosteronism • Congenital adrenal hyperplasia • Inter-sexing and virilisation • Hypokalaemic alkalosis • Causes of hypokalaemia and hypertension / normotension • Aldosterone and serum potassium control • Bartter's syndrome • Liddle's syndrome • Gittleman's syndrome • ECG changes in hypo and hyperkalaemia • Calcium control • Hormonal control of serum calcium concentration • Sites of action and mechanism of action of vitamin D and pTH • Primary hyperparathyroidism • Secondary and tertiary hyperparathyroidism • Pseudo-hyperparathyroidism vs. pseudo-pseudo-hyperparathyroidism • Osteomalacia • Paget's disease • Characteristic radiographic findings in hyperparathyroidism, malignancy, Paget's, osteomalacia and hypoparathyroidism • Diagnosis and pathophysiology of multiple myeloma • Symptoms and treatment of hypo and hypercalcaemia • Hyperthyroidism • Features and treatment of a thyroid crisis • Pregnancy and thyroid hormones • Pregnancy and the treatment of hyperthyroidism • Hyperthyroidism vs. Grave's • MEN I, IIa, IIb • Phaeochromocytoma • Features of hypo and hyperthyroidism • Diseases associated with hyperthyroidism • Thyroid cancers • Bleeding • Coagulation factors • Haemophilia • von Willebrand disease • Platelet and factor deficiency bleeding patterns • Abnormal INR and APTTr interpretation • Mechanism of warfarin, unfractionated and fractionated heparin • Vitamin K related coagulation factors • DIC • Fibrinolysis • Use of blood products in treating coagulopathy • Coeliac disease • Causes of subtotal villous atrophy • Malabsorption • Whipple’s disease • Dyspepsia • Criteria for endoscopy in those with dyspepsia • Test and treat protocol • H-pylori • Risk factors for gastric cancer • Thrombophilia • Pro-thrombotic vs. anti thrombotic factors • Thrombophilia screening • Factor V Leiden • Protein C & S deficiency • Antiphospholipid syndrome • Explanation of the 50:50 mix • Antithrombin III deficiency • Thrombosis and the oral contraceptive pill • Haemolysis • Diagnostic tests in patients with haemolysis • Intravascular and extravascular haemolysis, causes and mechanism • MAHA • Interpreting Coombs' tests • TTP and HUS • Splenic function • Splenectomy and autosplenectomy • PNH • Post splenectomy prophylaxis • Barrett's • Oesophageal cancer • GORD • Factors involved in gastric acid secretion • Urea breath test • Lymphoma • Overview of different lymphomas • Ann Arbor Staging • Monoclonal antibody therapy in haematological disease • Leukoerythroblastic blood film • Mechanisms and causes of splenomegaly • Multiple sclerosis • Diagnosis, presentation, prognostic features and treatment of MS • Optic neuritis • Scleritis vs. Episcleritis • RAPD • Afferent and efferent pathways of pupillary control • Nystagmus • Trigeminal neuralgia • Intranuclear ophthalmoplegia • Leukaemia's • Presentation of different leukaemias • Prognostic features in leukaemia • Chromosomal translocations • The importance of acute promyelocytic leukaemia • Treatment rationales in haematological malignancies • Renal tubular acidosis • Mechanism of RTA type I, II and IV • Causes of RTA • Fanconi syndrome • Proximal vs. distal tubular function • Acid base balance and the kidney • Cystinuria, Cystinosis and Homocystinuria • Anion gap and causes of abnormalities • Kidney stones • Connective tissue disorders • Pathophysiology, triggers and treatment of SLE • Use of serology in SLE • Limited cutaneous systemic sclerosis • Diffuse cutaneous systemic sclerosis • Sjogren's syndrome • Dermatomyositis • The autoimmune profile • Lung fibrosis in rheumatological conditions • Kidney damage in connective tissue disease • Movement disorders • Postural, resting and intention tremors • Dystonia • Athetosis • Myoclonus • Chorea • Parkinsonism • Parkinson’s disease • Parkinson’s Plus • Wilson’s disease • Huntington's disease • Fibrotic lung disease • TLCO / DLCO • Upper lobe vs. Lower lobe • PFT's • Anomalies in transfer factor values • Restrictive lung disease • Drugs causing lung fibrosis • EAA vs. CFA • Rheumatological diseases and the lung • Hepatitic blood picture • Cholestatic blood picture • Liver enzymes • Primary biliary cirrhosis • Primary sclerosing cholangitis • Primary prevention of oesophageal varices • Hepatitis B serology • Treatment of viral hepatitis • Treatment of variceal bleed • Ascites causes and diagnostic tests • Lung cancers • Paraneoplastic syndromes • Staging of NSCLC and SCLC • Criteria precluding surgery in NSCLC • Aetiology of pleural effusions • Light's criteria • Cavitating infections • Sites of lung cancer • Myasthenia gravis and Lambert Eaton myasthenic syndrome • Paraneoplastic disorders • Edrophonium (tensilon test) • Causes of autonomic neuropathy • Features of autonomic neuropathy • Cholinergic crisis • Myasthenic crisis • Characteristic EMG findings